ZYPREXA VELOTAB 10mg Tablets/Orodispersible Price, Uses, Alternatives, Dose, and more in UAE 2023
ZYPREXA VELOTAB 10mg Tablets/Orodispersible
Drug name ZYPREXA VELOTAB 10mg
Active substance Olanzapine
Size : 28 s (7 s Blister x 4)
Company : ELI LILLY & CO LTD.
Uploaded By : Admin
ٍ Visits : 382 visit
What is Zyprexa Velotab?
Olanzapine is an antipsychotic medicine that affects chemicals in the brain.
The principle of action of olanzapine is that it binds to dopamine and serotonin receptors and influences their action.
What are the uses of Zyprexa Velotab?
Olanzapine is used in the treatment of the following diseases and psychological problems:
Treatment of mixed mania or severe mania associated with bipolar disorder or schizophrenia.
Treating severe depression.
Treatment of depression associated with bipolar disorder.
How to use Zyprexa Velotab
Take with food if stomach upset.
You should drink plenty of fluids, except for caffeine.
You must follow the diet prescribed by your doctor.
Avoid stopping the medication suddenly without contacting your doctor
If symptoms do not improve within two to three weeks, you should contact your doctor.
The treatment may cause a significant increase in weight, so it is advised to monitor the patient s weight and waist circumference.
Welcome to Dwaey, specifically on ZYPREXA VELOTAB 10mg Tablets/Orodispersible page.
This medicine contains an important and useful components, as it consists of Olanzapine.
ZYPREXA VELOTAB 10mg is available in the market in concentration 10mg/Tablet and in the form of Tablets/Orodispersible.
ELI LILLY & CO LTD. is the producer of ZYPREXA VELOTAB 10mg and it is imported from UK.
The most popular alternatives of ZYPREXA VELOTAB 10mg are listed downward .
Lets know how to use ZYPREXA VELOTAB 10mg Tablets/Orodispersible
Angle-closure glaucoma; lactation. IM: History of CVS disease, heart surgery.
Patient w/ cerebrovascular disease or conditions predisposing to hypotension, benign prostatic hyperplasia, paralytic ileus, DM, Parkinson's disease, history of blood dyscrasias, bone marrow depression, hypereosinophilic disorders, myeloproliferative disease, history of seizures or conditions that lower the seizure threshold. IM: Acute MI, unstable angina, severe hypotension or bradycardia, sick sinus syndrome, recent heart surgery. Elderly w/ dementia-related psychosis. Hepatic and renal impairment. Pregnancy and lactation. Patient Counselling This drug may cause somnolence and dizziness, if affected, avoid driving and operating machinery. Avoid cigarette smoking. Monitoring Parameters Monitor BP, pulse and resp rate for at least 4 hr after IM inj. Clinical monitoring for hyperglycaemia, plasma lipids and wt. Lactation: Drug enters breast milk; not recommended
Olanzapine is an atypical antipsychotic with affinity for serotonin 5-HT2A/2C, dopamine, muscarinic M1-M5, histamine H1 and adrenergic ?1 receptors.
Olanzapine may antagonise the effects of levodopa and dopamine agonists. Drugs that induce CYP1A2 or glucuronyl transferase enzymes e.g. omeprazole and rifampicin, may increase olanzapine clearance. Inhibitors of CYP1A2 may potentially inhibit olanzapine elimination. Carbamazepine may increase the clearance of olanzapine. Concomitant admin of activated charcoal reduced the oral bioavailability of olanzapine by 50-60%. Caution should be taken when olanzapine is administered with centrally acting drugs and alcohol.